Shoari A, Ashja Ardalan A, Dimesa A, Coban M
Biomolecules. 2025; 15(1).
PMID: 39858430
PMC: 11762759.
DOI: 10.3390/biom15010035.
Gui Z, Zhang Y, Zhang A, Xia W, Jia Z
Front Immunol. 2023; 13:1057980.
PMID: 36618379
PMC: 9815110.
DOI: 10.3389/fimmu.2022.1057980.
Jorgensen B, Ro S
Int J Mol Sci. 2022; 23(4).
PMID: 35216281
PMC: 8876324.
DOI: 10.3390/ijms23042166.
Chang T, Wu C, Sheu M, Yang R, Liu S
Cancers (Basel). 2021; 13(23).
PMID: 34885061
PMC: 8657120.
DOI: 10.3390/cancers13235946.
Li J, Xiang Q, Wang M, Zhang H, Liang R
J Oncol. 2021; 2021:5338934.
PMID: 34335757
PMC: 8318767.
DOI: 10.1155/2021/5338934.
Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer.
Feng J, Wei Q, Yang M, Wang X, Liu B, Li J
Ann Transl Med. 2021; 9(9):747.
PMID: 34268360
PMC: 8246165.
DOI: 10.21037/atm-20-1751.
MicroRNA‑16‑5p/BIMP1/NF‑κB axis regulates autophagy to exert a tumor‑suppressive effect on bladder cancer.
He J, Qiu Z, Zhang H, Gao Z, Jiang Y, Li Z
Mol Med Rep. 2021; 24(2).
PMID: 34132358
PMC: 8223104.
DOI: 10.3892/mmr.2021.12215.
MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Xu F, Ye M, Zhang Y, Li W, Li M, Wang H
Cancer Sci. 2020; 111(5):1528-1541.
PMID: 32073706
PMC: 7226198.
DOI: 10.1111/cas.14356.
CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L, He K, Cao Z, Bi L, Yu D, Wang Q
Mol Med Rep. 2020; 21(1):329-337.
PMID: 31939627
PMC: 6896372.
DOI: 10.3892/mmr.2019.10840.
Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells.
Forouzan Jahromi Z, Javeri A, Taha M
EXCLI J. 2019; 18:243-252.
PMID: 31217787
PMC: 6558512.
DOI: 10.17179/excli2019-1166.
MicroRNA-195: a review of its role in cancers.
Yu W, Liang X, Li X, Zhang Y, Sun Z, Liu Y
Onco Targets Ther. 2018; 11:7109-7123.
PMID: 30410367
PMC: 6200091.
DOI: 10.2147/OTT.S183600.
CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
McAuley J, Freeman T, Ekambaram P, Lucas P, McAllister-Lucas L
Front Immunol. 2018; 9:1887.
PMID: 30158935
PMC: 6104486.
DOI: 10.3389/fimmu.2018.01887.
MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1.
Cao S, Lin L, Xia X, Wu H
Oncotarget. 2018; 9(1):321-331.
PMID: 29416616
PMC: 5787468.
DOI: 10.18632/oncotarget.20109.
Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.
Koduru S, Leberfinger A, Ravnic D
J Genomics. 2017; 5:99-118.
PMID: 28943972
PMC: 5607708.
DOI: 10.7150/jgen.22060.
MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.
Shuang Y, Li C, Zhou X, Huang Y, Zhang L
Oncol Rep. 2017; 38(4):2155-2165.
PMID: 28791411
PMC: 5652960.
DOI: 10.3892/or.2017.5875.
miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.
Yan J, Chang Y, Zhang Y, Lin J, He X, Huang H
Oncol Lett. 2017; 13(5):3118-3126.
PMID: 28529562
PMC: 5431445.
DOI: 10.3892/ol.2017.5826.
MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.
Strubberg A, Madison B
Dis Model Mech. 2017; 10(3):197-214.
PMID: 28250048
PMC: 5374322.
DOI: 10.1242/dmm.027441.
MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway.
Zhang X, Xu J, Jiang T, Liu G, Wang D, Lu Y
Am J Cancer Res. 2016; 6(11):2631-2640.
PMID: 27904776
PMC: 5126278.
Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.
Yang I, Tsai H, Miao Z, Huang C, Kuo C, Wu J
J Transl Med. 2016; 14(1):108.
PMID: 27126129
PMC: 4850676.
DOI: 10.1186/s12967-016-0856-2.
MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
Wang M, Zhang J, Tong L, Ma X, Qiu X
Int J Clin Exp Pathol. 2016; 8(11):14110-20.
PMID: 26823724
PMC: 4713510.